Schechter Investment Advisors LLC Has $6.64 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Schechter Investment Advisors LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,676 shares of the healthcare conglomerate's stock after selling 1,527 shares during the quarter. Schechter Investment Advisors LLC's holdings in UnitedHealth Group were worth $6,639,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Financial Management Professionals Inc. boosted its position in shares of UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Richwood Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares during the period. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after acquiring an additional 21 shares during the period. Finally, Retirement Planning Group LLC raised its holdings in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after acquiring an additional 21 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on UNH shares. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Barclays lowered their price target on shares of UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating on the stock in a research note on Wednesday. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Finally, JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday, June 20th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $415.00.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $4.30 during midday trading on Friday, hitting $303.81. 9,789,082 shares of the company were exchanged, compared to its average volume of 7,703,876. The firm has a market capitalization of $275.60 billion, a P/E ratio of 12.72, a PEG ratio of 1.46 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm's 50 day moving average price is $314.52 and its two-hundred day moving average price is $440.43. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the firm earned $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.